A 34-year-old woman, gravida 2, para 1, at 38 weeks gestation is admitted to the labor and delivery unit for induction of labor due to preeclampsia with severe features. Her medical history is notable for mild persistent asthma, for which she uses an inhaled corticosteroid. She is receiving intravenous magnesium sulfate for seizure prophylaxis and an intravenous oxytocin infusion for labor augmentation. Maintenance intravenous fluids are running at 125 mL/hr. Fourteen hours into her induction, she becomes acutely agitated and reports sudden-onset severe shortness of breath and chest tightness. She states she is unable to lie flat.
Vital signs are:
Temperature: 37.0°C (98.6°F)
Blood pressure: 172/112 mmHg
Heart rate: 118/min
Respiratory rate: 28/min
SpO2: 86% on room air
Physical examination reveals prominent jugular venous pulsations. Lung auscultation reveals scattered wheezes and bilateral fine crackles extending to the mid-lung fields. The fetal heart rate tracing demonstrates a baseline of 140/min, moderate variability, and symmetric, gradual decreases in the heart rate that nadir exactly at the peak of uterine contractions.
An arterial blood gas on room air shows:
pH: 7.44
PaCO2: 28 mmHg
PaO2: 58 mmHg
HCO3: 19 mEq/L
The patient is immediately placed on supplemental oxygen via a non-rebreather mask. Which of the following is the most appropriate next step in the management of this patient?
- Intravenous furosemideCevap
- BAlbuterol sulfate nebulization
- CEmergency Cesarean delivery
- DIntravenous sodium bicarbonate
- EReassurance and continued observation